DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 214 filers reported holding DENALI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $24,000 | -17.2% | 800 | -12.1% | 0.01% | 0.0% |
Q1 2022 | $29,000 | -19.4% | 910 | +12.2% | 0.01% | -16.7% |
Q4 2021 | $36,000 | +100.0% | 811 | +125.3% | 0.01% | +100.0% |
Q3 2021 | $18,000 | -41.9% | 360 | -9.8% | 0.00% | -50.0% |
Q2 2021 | $31,000 | +55.0% | 399 | +14.0% | 0.01% | +20.0% |
Q1 2021 | $20,000 | -31.0% | 350 | 0.0% | 0.01% | -28.6% |
Q4 2020 | $29,000 | +61.1% | 350 | -30.0% | 0.01% | +16.7% |
Q3 2020 | $18,000 | -78.8% | 500 | -85.7% | 0.01% | -81.8% |
Q2 2020 | $85,000 | -3.4% | 3,500 | -30.0% | 0.03% | -17.5% |
Q1 2020 | $88,000 | +3.5% | 5,000 | +2.0% | 0.04% | +25.0% |
Q4 2019 | $85,000 | +466.7% | 4,900 | +390.0% | 0.03% | +357.1% |
Q3 2019 | $15,000 | -25.0% | 1,000 | 0.0% | 0.01% | -22.2% |
Q2 2019 | $20,000 | -4.8% | 1,000 | 0.0% | 0.01% | -18.2% |
Q1 2019 | $21,000 | -97.7% | 1,000 | -97.7% | 0.01% | -98.1% |
Q4 2018 | $899,000 | -7.0% | 43,518 | -5.1% | 0.59% | +2.6% |
Q3 2018 | $967,000 | +16.8% | 45,838 | -15.6% | 0.58% | -34.8% |
Q2 2018 | $828,000 | -11.1% | 54,305 | +9.4% | 0.88% | +28.4% |
Q1 2018 | $931,000 | – | 49,642 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |